Samsung Medical Center
Seoul, 135-710, South Korea
NCT Number: NCT02081222
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Looking for future studies?
Notify MeUp to 10 year
All sexes
Observational
Seoul, 135-710, South Korea
Viscoelastic hemostatic assay has been reported to be superior to predict perioperative bleeding in cardiac surgical patients compared with conventional blood coagulation test. However, the role of rotational thromboelastometry (ROTEM) in predicting perioperative bleeding and transfusion requirements in pediatric patients who undergoing surgery for congenital heart disease. Therefore, the investigators attempt to evaluate the predictability of intraoperative rotational thromboelastometry for perioperative bleeding and transfusion requirements in pediatric cardiac surgical patients by comparing with conventional coagulation test. The investigators also attempt to evaluate the correlation between ROTEM parameters, platelet count, and results of conventional coagulation test results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
surgery for congenital heart disease with cardiopulmonary bypass
Time frame: during seven days after surgery
daily blood loss measured by chest tube drainage during seven days after surgery
Time frame: during seven days after surgery
postoperative transfusion requirements during seven days after surgery
Samsung Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02704351
Suggamadex, Surgery for Congenital Heart Disease
Columbus, Ohio, United States
View Trial DetailsNCT01330433
Cardiovascular Abnormalities, Cardiovascular Diseases
Loma Linda, California, United States
View Trial DetailsNCT00994994
Blood Loss, Cardiovascular Abnormalities
View Trial DetailsNCT07066748
Cardiovascular Abnormalities, Cardiovascular Diseases
Alexandria, Alexandria Governorate, Egypt
View Trial Details